Viewing Study NCT03946969


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-02-20 @ 10:10 PM
Study NCT ID: NCT03946969
Status: UNKNOWN
Last Update Posted: 2022-07-19
First Post: 2019-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant View
None Esophageal Cancer View
None PD-1 View